# K133445: Angiovac Cannula

- Pathway: 510(k) (Traditional)
- Applicant: Vortex Medical, Inc.
- Decided: Mar 5, 2014 after 113 days
- Product code: DWF (Catheter, Cannula And Tubing, Vascular, Cardiopulmonary Bypass)
- Device class: 2
- Regulation: 21 CFR 870.4210
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 1 generation back to K091304 (2009). 1 ancestor in all.
4 later devices descend from it; 1 cites it directly.
0 of 6 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K091304: Vortex Cannula, Vortex Medical, Inc. (2009) Summary page 1.

## Most influential descendants
- K142593: AngioVac Cannula (2014), 3 descendants of its own
- K190594: AngioVac C20, AngioVac C180 (2019), 2 descendants of its own
- K253106: AngioVac Cannula (2025), 0 descendants of its own
- K212386: AngioVac F18 85 (2021), 0 descendants of its own

## Indications for use
The AngioVac Cannula is indicated for use as a venous drainage cannula during extracorporeal bypass for up to 6 hours. The cannula is also indicated for removal of fresh, soft thrombi or emboli during extracorporeal bypass for up to 6 hours.

Source page: https://510kreport.com/device/K133445
Methodology: https://510kreport.com/methodology